India to Singapore: Regorafenib Export Trade Route
India has recorded 9 verified shipments of Regorafenib exported to Singapore, representing a combined trade value of $17.6K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $2.0K USD. The leading Indian exporter is P.B.P ENTERPRISES PRIVATE LIMITED, which accounts for 45% of total export value with 3 shipments worth $7.9K USD. On the buying side, TO THE ORDER is the largest importer in Singapore with $6.0K USD in purchases. The top 3 suppliers — P.B.P ENTERPRISES PRIVATE LIMITED, LEOWIN HEALTHCARE LLP, HEET HEALTHCARE PRIVATE LIMITED — together control 91% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Singapore Regorafenib corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $17.6K USD. The route is dominated by P.B.P ENTERPRISES PRIVATE LIMITED, which alone accounts for roughly 45% of all export value, reflecting the consolidated nature of India's regorafenib manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $2.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (33.33%) and air (66.67%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October-December, with an average transit time of 7 days port-to-port. The route has recorded an annual growth rate of 23.6%, placing it at rank #10 among India's top regorafenib export destinations globally.
On the import side, key buyers of Indian regorafenib in Singapore include TO THE ORDER, TO THE ORDER OF THE MANAGER, RADEEP SERVICES and 3 others. TO THE ORDER is the single largest importer with 3 shipments valued at $6.0K USD.
